Skip to content

Kinect-based Upper Limb Rehabilitation System in Stroke Patients

Effect of Kinect-based Upper Limb Rehabilitation System in Patients With Stroke: A Pilot Trial

Status
Terminated
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02066116
Enrollment
23
Registered
2014-02-19
Start date
2014-11-30
Completion date
2017-11-30
Last updated
2017-11-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hemiplegia, Stroke, Virtual Rehabilitation

Brief summary

The investigators have developed the kinect-based upper extremity rehabilitation program and designed this protocol to prove the efficacy of this program. In brief, subacute stroke patients allocated to intervention group will receive the kinect based-rehabilitation program plus conventional occupational therapy and patients allocated to control group will receive the sham virtual rehabilitation plus conventional occupational therapy, for 10 days. 20 patients with subacute stroke will be allocated into each group and after completing the 10 days intervention, they will be assessed by using objective assessment tools for upper extremity function.

Interventions

PROCEDUREKinect-based rehabilitation plus occupational therapy

The developed kinect-based rehabilitation system will be used for 30min/session. Conventional 30min occupational therapy also will be applied for the patient enrolled.

OTHERsham virtual rehabilitation education plus occupational therapy

For the sham virtual rehabilitation, computer-based cognitive rehabilitation program will be used. Patients will be encouraged to use their affected arm to push the button but the motion will be minimal and not related to the concept of upper extremity rehabilitation.

Sponsors

Microsoft Research
CollaboratorINDUSTRY
Ministry of Science and ICT, Republic of Korea
CollaboratorOTHER_GOV
Seoul National University Bundang Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
TRIPLE (Subject, Caregiver, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
20 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* Age from 20 to 80 years * Stroke within prior 3 months * Unilateral upper extremity weakness

Exclusion criteria

* Uncontrolled medical conditions * Who cannot obey the simple command * Who has the hemispatial neglect, visual impairment, apraxia

Design outcomes

Primary

MeasureTime frame
Change from Baseline in Fugl-Meyer Assessment Scale for upper extremity at 2 weeksBaseline, 2 weeks after the baseline

Secondary

MeasureTime frameDescription
Brunnstrom stageBaseline, 2 weeks after the baseline, 6 weeks after the baseline, 14 weeks after the baselineThis is composed of 6 stages. Higher score means better function. The description for each stage as follows. 1. Flaccidity: no voluntary movement. 2. Synergies or minimal voluntary movement. 3. Synergies performed voluntary (spasticity gratest). 4. Some deviation from synergy. 5. Independent or isolated movement. 6. Individual joint movement nearly normal with minimal spasticity.
Modified Barthel IndexBaseline, 2 weeks after the baseline, 6 weeks after the baseline, 14 weeks after the baseline
Box and Block TestBaseline, 2 weeks after the baseline, 6 weeks after the baseline, 14 weeks after the baselineIndividuals are seated at a table, facing a rectangular box that is divided into two square compartments of equal dimension by means of a partition. One hundred and fifty, 2.5 cm, colored, wooden cubes or blocks are placed in one compartment or the other. The individual is instructed to move as many blocks as possible, one at a time, from one compartment to the other for a period of 60 seconds. The BBT is scored by counting the number of blocks carried over the partition from one compartment to the other during the one-minute trial period.
Number of movement counts during rehabilitation using accelerometer dataBaseline, 2 weeks after the baseline

Countries

South Korea

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026